NewsVoir
Ahmedabad (Gujarat) [India], August 5: India's pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the world's largest medicine markets, millions of Indian families continue to struggle with the high cost of treatment. Studies show that over 50% of healthcare expenses in India are still paid out-of-pocket, leaving many to either delay care or make painful trade-offs between health and household priorities. In this environment, the need for accessible and affordable options is critical. This is where smart, tech-enabled platforms focused on generic medicines are stepping up. The growing shift toward generics, supported by stricter manufacturing standards and better public awareness, is unlocking a new healthcare era for India, one where savings don't have to mean sacrifice.
The Industry Context: Healthcare Costs and E-Pharmacy Boom
India's healthcare system places a significant financial burden on individuals, with many patients still covering treatment costs themselves. According to the National Health Accounts Estimates 2021-22 released by the Ministry of Health and Family Welfare, out-of-pocket expenditure accounted for approximately 39.4% of total health spending, down from 62.6% in 2014-15, but still substantial. This is particularly challenging for families managing chronic conditions like diabetes or hypertension, where monthly medicine expenses quickly add up but there is hardly any insurance that covers it. Meanwhile, a widespread lack of awareness persists: many patients are still unaware that most branded drugs have affordable generic counterparts, regulated for safety and efficacy by India's pharmaceutical standards.
Moreover, while generic medicines make up nearly 70% of India's pharma volume, a persistent perception problem remains: Are they as good as brands? Can they be trusted? These doubts, often fueled by misinformation and inconsistent supply chains, have kept many patients from making the switch.
Medkart is changing that.
What Medkart Solves: A System Plagued by Price Confusion and Inequity
Despite the availability of generics, most Indian consumers continue to purchase costly branded medicines due to a lack of information, trust, or local access. Chronic disease patients - especially those with diabetes or hypertension, which account for approximately 68% of India's chronic illness burden are hit hardest by monthly bills.
Many tier-2 and rural customers also struggle with access. A patient needing basic chronic meds often travels kilometres, pays for branded substitutes, and ends up spending nearly 30% of household income on drugs alone.
Medkart: India's Smartest Generic App Platform
Medkart's app is designed as the simplest platform to use for smart medicine buying
- Generic Medicine Comparison Engine: India's first price-comparison tool for generics lets users compare prices and compositions instantly. Voriconazole, a multipurpose drug, shows savings of up to 86% (MRP Rs. 5,192 vs Medkart's price Rs. 720).
- Chronic Disease Navigation: Medicines are categorised into disease buckets (Diabetes, BP, Kidney, Heart), aligned with India's leading disease burdens.
- Prescription Upload & Matching: Users upload their prescription, and the app matches it with "Medkart Assured" generics, tested for Schedule M compliance and plant-audited.
- WhatsApp Integration: With nearly 600M Indian WhatsApp users, Medkart offers order placement via WhatsApp, breaking digital barriers for older and rural patients.
- Store + Delivery Hybrid Model: With 100+ retail stores and coverage across 35,000+ pin codes, Medkart offers online delivery with COD or many ways to pay.
Scale and Impact
- Savings Delivered: Rs. 650 crore saved across 11+ lac users
- Reach: 60 lakh orders fulfilled; 11+ Lac families served
- Coverage: 35,000+ pincodes - deeper than most e-pharmacies
- App Features: Available in Hindi, English, and Gujarati
Smarter Pharmacy, Healthier India
With India's generic medicine market gaining momentum and digital health adoption rising across Tier 2 and Tier 3 cities, Medkart is bridging critical gaps in access, trust, and affordability. Its transparent pricing, disease-specific drug discovery, and hybrid delivery-retail model empower patients to make informed choices without compromising on quality.
As the demand for affordable healthcare surges, Medkart is not just responding, it's reshaping how India buys medicines. By building India's smartest generic pharmacy platform, Medkart is making quality healthcare both accessible and sustainable for millions.
Switch smart, save more. Download the Medkart App or visit www.medkart.in to explore up to 85% savings on generics.
Medkart - Aapka Shubhchintak.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by NewsVoir. ANI will not be responsible in any way for the content of the same)
